SarbeyB: Why standard drug treatments for the “Death Rattle” should be discontinued. J Palliat Med, 2022; 25:180.
2.
van EschHJ, van ZuylenL, GeijtemanECT, et al.: Effect of prophylactic subcutaneous scopolamine butylbromide on death rattle in patients at the end of life: The SILENCE randomized clinical trial. JAMA, 2021; 326:1268–1276.
3.
LoweJR, and HansonLC: Preventing death rattle with prophylactic subcutaneous scopolamine butylbromide. JAMA, 2021; 326:1263–1265.
